Integrating scientific knowledge with today's most effective treatment options, Addiction Medicine: Science and Practice, 2nd Edition, provides a wealth of information on addictions to substances and behavioral addictions. It discusses the concrete research on how the brain and body are affected by addictions, improving your understanding of how patients develop addictions and how best to personalize treatment and improve outcomes. This essential text is ideal for anyone who deals with patients with addictions in clinical practice, including psychiatrists, health psychologists, pharmacologists, social workers, drug counselors, trainees, and general physicians/family practitioners.
- Clearly explains the role of brain function in drug taking and other habit-forming behaviors, and shows how to apply this biobehavioral framework to the delivery of evidence-based treatment.
- Provides clinically relevant details on not only traditional sources of addiction such as cocaine, opiates, and alcohol, but also more recently recognized substances of abuse (e.g., steroids, inhalants) as well as behavioral addictions (e.g., binge eating, compulsive gambling, hoarding).
- Discusses current behavioral and medical therapies in depth, while also addressing social contexts that may affect personalized treatment.
- Contains new information on compliance-enhancing interventions, cognitive behavioral treatments, behavioral management, and other psychosocial interventions.
- Includes neurobiological, molecular, and behavioral theories of addiction, and includes a section on epigenetics.
- Contains up-to-date information throughout, including a new definition of status epilepticus, a current overview of Lennox Gastaut syndrome, and updates on new FDA-approved drugs for pediatric neurological disorders.
- Features expanded sections on evidence-based treatment options including pharmacotherapy, pharmacogenetics, and potential vaccines.
- Addresses addiction in regards to specific populations, including adolescents, geriatric, pregnant women, and health care professionals.
- Includes contributions from expert international authors, making this a truly global reference to addiction medicine.
Auflage
Sprache
Verlagsort
Verlagsgruppe
Elsevier HealthScience EN
Illustrationen
ISBN-13
978-0-323-68053-0 (9780323680530)
Schweitzer Klassifikation
Part I: History, Perspective, Epidemiology, Dx and Classification1. Emerging Health Perspectives2. The Epidemiology of Alcohol and Drug Disorders3. United States Federal Drug Policy4. Historical Perspectives of Addiction5. Diagnosis and Classification of Substance Use DisordersPart II: Behavioral Theories for Substance Use Disorder6. Drug Reinforcement in Animals7. Role of the Human Laboratory Studies in the Development of Medications for Alcohol and Substance Abuse Disorders8. Conditioning of Addiction9. Overlapping Striatal Circuits and Molecular Mechanisms in Rodent Models of Addiction and Depression10. The Role of Endocannabinoids in Amphetamine-Driven Actions in Dopamine Neurons: Implications for Understanding and Treating Dysfunction in the Mesolimbic Circuit11. Pain and Negative Affect12. Genetic Vulnerability to Substance Use Disorders13. Assessment and Treatment of Addiction in Best Practices and New Frontiers in a Direct to Consumer Age14. Metabolomics in Drug Response and AddictionPart III: Visualizations and Workings of the Addicted Brain15. Visualization and Workings of the Addicted Brain16. Neurobiological Basis of Drug Reward and Reinforcement17. Neurobehavioral Toxicology of Substances of Abuse18. Animal Models of Substance Use Disorders: Motivational Perspective19. Novel Methodologies: Proteomic Approaches in Substance Abuse Research20. Neuroinflammatory Processes in Drug AddictionPart IV: Clinical Aspects of Alcohol and Drug Addiction21. Alcohol: Clinical Aspects22. Cocaine23. Nicotine24. Cannabis: An Overview of the Empirical Literature25. Opiates and Prescription Drugs26. Clinical Aspects of Methamphetamine27. Sedative-Hypnotics and Anxiolytics28. Clinical Aspects of Inhalant Addiction29. Anabolic-Androgenic Steroids30. Caffeine31. Serotonergic Hallucinogens32. Ketamine and PhencyclidinePart V: Behavioral Addictions and Treatment33. The Biology and Treatment of Pathological Gambling34. Implications of "Food Addiction" for Understanding and Treating Binge Eating Disorder35. Compulsive Buying36. Sexual Behavior as an Addictive or Compulsive Phenomenon37. New Era of Internet Addiction Research in China38. Hoarding as a Behavioral AddictionPart VI: Treatment and Application: Behavioral Treatments39. Motivational Interviewing: Emerging Theory, Research, and Practice40. Cognitive Behavioral Therapy for Addiction41. Community Reinforcement Approach and Contingency Management Therapies42. Relapse Prevention and Recycling in Addiction43. Brief and e-Health Interventions for the Treatment of Alcohol or Other Drug Addiction 44. Self-Help Approaches for AddictionSection VII: Treatment and Application: Group Treatments and Specific Settings45. Community Clinics46. Unhealthy Alcohol and Other Drug Use in Primary Care47. Criminal Justice System and Addiction Treatment48. Adolescent Neurocognitive Development and School-Based Drug Abuse Prevention and Treatment49. The Therapeutic Community for Drug-Abuse Treatment: A Journey Yet Unfolding in the Recovery Movement50. Substance Use-Focused Mutual-Help Groups: Processes and OutcomesSection VIII: Treatment and Application Pharmacotherapy51. Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings52. Alcohol Withdrawal: Treatment and Application53. Pharmacotherapy of Cocaine Addiction54. Opioid Overdose55. Methamphetamine56. Potential Pharmacotherapies for Cannabis Dependence57. HallucinogensSection IX: Molecular Genetics, Alternative Therapies, and Other Topics in the Treatment of Addiction58. Molecular Genetics and the Treatment of Addiction59. Physical Considerations for Treatment Complications of Alcohol and Drug Use and Misuse60. Quadruple Diagnosis: Substance Use Disorder, Comorbid Psychopathology, Human Immunodeficiency Virus Infection, and Hepatitis C Virus Infection61. Substance Use Stigma as a Barrrier to Treatment and Recovery62.
